Tags

Type your tag names separated by a space and hit enter

Beta-blockers in the prevention of gastrointestinal bleeding.
Rev Invest Clin. 1990 Jul; 42 Suppl:159-64.RI

Abstract

Betablockers were introduced in Hepatology 10 years ago as vasoactive drugs to reduce portal pressure. Utilization to prevent recurrent gastrointestinal bleeding in patients with portal hypertension has been widely evaluated through the years. More recently, this approach has been used to prevent a first variceal bleeding episode. Meta-analysis evaluation of 5 large controlled trials shows that with P-blockers, first hemorrhagic episode ocurred in 10% verus 30% which ocurred with placebo after one year. Re-bleeding episodes with beta-blockers ocurred in 44% of the patients after 2 years of followup and in 65% of patients receiving placebo.

Authors+Show Affiliations

Laboratoire d'Hémodynamique Splanchnique, Unité de Recherches de Physiopathlogie Hépatique (INSERM U-24), Hopital Beaujon, Clichy, France.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

19256157

Citation

Lebrec, L. "Beta-blockers in the Prevention of Gastrointestinal Bleeding." Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion, vol. 42 Suppl, 1990, pp. 159-64.
Lebrec L. Beta-blockers in the prevention of gastrointestinal bleeding. Rev Invest Clin. 1990;42 Suppl:159-64.
Lebrec, L. (1990). Beta-blockers in the prevention of gastrointestinal bleeding. Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion, 42 Suppl, 159-64.
Lebrec L. Beta-blockers in the Prevention of Gastrointestinal Bleeding. Rev Invest Clin. 1990;42 Suppl:159-64. PubMed PMID: 19256157.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Beta-blockers in the prevention of gastrointestinal bleeding. A1 - Lebrec,L, PY - 2009/3/5/entrez PY - 1990/7/1/pubmed PY - 2009/4/25/medline SP - 159 EP - 64 JF - Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion JO - Rev Invest Clin VL - 42 Suppl N2 - Betablockers were introduced in Hepatology 10 years ago as vasoactive drugs to reduce portal pressure. Utilization to prevent recurrent gastrointestinal bleeding in patients with portal hypertension has been widely evaluated through the years. More recently, this approach has been used to prevent a first variceal bleeding episode. Meta-analysis evaluation of 5 large controlled trials shows that with P-blockers, first hemorrhagic episode ocurred in 10% verus 30% which ocurred with placebo after one year. Re-bleeding episodes with beta-blockers ocurred in 44% of the patients after 2 years of followup and in 65% of patients receiving placebo. SN - 0034-8376 UR - https://www.unboundmedicine.com/medline/citation/19256157/Beta_blockers_in_the_prevention_of_gastrointestinal_bleeding_ L2 - https://medlineplus.gov/gastrointestinalbleeding.html DB - PRIME DP - Unbound Medicine ER -